Cuprina (Cayman) (CUPR) vs NexGel (NXGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Cuprina (Cayman) is the larger company by market cap ($11.8 million vs $97,622), about 121.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CUPR | NXGL |
|---|---|---|
| Share price | $1.69 | $0.2003 |
| Market cap | $11.84M | $97.62K |
| 1-day change | -11.05% | +33.53% |
| YTD return | -47.19% | — |
| 1-year return | -80.44% | — |
| EPS (TTM) | $-1.40 | $-14.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.80 | $57.00 |
| 52-week low | $1.45 | $0.151 |
| Distance from 52-week high | -88.58% | -99.65% |
| Analyst consensus | — | hold |
| Average volume | 95.27K | 37.86K |
| Shares outstanding | 5.24M | 487.38K |
| Employees | 10 | 19 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cuprina (Cayman) is about 121.2 times larger than NexGel by market value ($11.84M vs $97.62K).
About Cuprina (Cayman)
CUPR stock →Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.
Health Care · Industrial Specialties · 10 employees
About NexGel
NXGL stock →NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Health Care · Medical/Dental Instruments · 19 employees
CUPR vs NXGL FAQ
Which is bigger, Cuprina (Cayman) or NexGel?
Cuprina (Cayman) (CUPR) is larger, with a market capitalization of $11.84M compared with $97.62K for NexGel (NXGL).
Are Cuprina (Cayman) and NexGel in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Cuprina (Cayman) and Medical/Dental Instruments for NexGel.